These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31243977)

  • 1. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
    Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
    Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.
    Dal Corso A; Pignataro L; Belvisi L; Gennari C
    Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.
    Panzeri S; Zanella S; Arosio D; Vahdati L; Dal Corso A; Pignataro L; Paolillo M; Schinelli S; Belvisi L; Gennari C; Piarulli U
    Chemistry; 2015 Apr; 21(16):6265-71. PubMed ID: 25761230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
    Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
    Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake.
    Pina A; Kadri M; Arosio D; Dal Corso A; Coll JL; Gennari C; Boturyn D
    Chemistry; 2020 Jun; 26(33):7492-7496. PubMed ID: 32227540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptides containing 2,5-diketopiperazine (DKP) scaffolds as shuttles for anti-cancer drugs: conformational studies and biological activity.
    Feni L; Jütten L; Parente S; Piarulli U; Neundorf I; Diaz D
    Chem Commun (Camb); 2020 May; 56(42):5685-5688. PubMed ID: 32319458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of integrin α
    Lv X; Zhang C; Shuaizhen Q; Yu R; Zheng Y
    Biomed Pharmacother; 2020 Aug; 128():110236. PubMed ID: 32447209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [
    Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S
    Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alphavbeta3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers.
    Rerat V; Dive G; Cordi AA; Tucker GC; Bareille R; Amédée J; Bordenave L; Marchand-Brynaert J
    J Med Chem; 2009 Nov; 52(22):7029-43. PubMed ID: 19860432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured Amphiphilic Star-Hyperbranched Block Copolymers for Drug Delivery.
    Seleci M; Seleci DA; Ciftci M; Demirkol DO; Stahl F; Timur S; Scheper T; Yagci Y
    Langmuir; 2015 Apr; 31(15):4542-51. PubMed ID: 25816726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.
    Liu Y; Mei L; Xu C; Yu Q; Shi K; Zhang L; Wang Y; Zhang Q; Gao H; Zhang Z; He Q
    Theranostics; 2016; 6(2):177-91. PubMed ID: 26877777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
    Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
    J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.